People who take semaglutide—the active ingredient in Ozempic and Wegovy—may have a higher risk of a rare eye condition called nonarteritic anterior ischemic optic neuropathy (NAION), which can ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Being prescribed semaglutide for diabetes or weight management is associated with an increased risk, up to seven times, of developing a relatively rare form of untreatable blindness, sometimes ...

Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss.. The risk of developing non-arteritic anterior ischemic ...

Study links Ozempic to higher risk of eye condition that can cause vision loss. By Elaine Chen July 3, 2024. Reprints.

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...

Recently published studies assert that Ozempic significantly increases the risk of developing a rare eye condition called non-arteritic anterior ischemic optic neuropathy, or NAION.

People who use Ozempic or Wegovy for treating obesity or Type 2 diabetes may have an increased risk of developing a rare form of blindness, according to a study published Wednesday in the journal ...

Ozempic may also be prescribed off-label for weight loss. Although the drug is intended for adults, there are special considerations for people over the age of 50, primarily those related to ...